Sudanese Advisor: Health agreed to establish new pharmaceutical factories in Iraq

POSTED ON[You must be registered and logged in to see this link.] BY [You must be registered and logged in to see this link.]

[size=52]Sudanese Advisor: Health agreed to establish new pharmaceutical factories in Iraq[/size]

[size=45]Hamoudi Al-Lami, Advisor to the Prime Minister for Industry Affairs and Private Sector Development, announced the approval of 56 applications to establish new pharmaceutical factories in Iraq, and while setting the conditions for granting licenses for pharmaceutical and medical preparations factories, he confirmed that there are international and European companies as well as Chinese and Indian companies to obtain offers from and select and import lines. Production.[/size]
[size=45]Al-Lami said, in a statement to the official agency, “The Ministry of Health is the body that determines the conditions for granting a license to a pharmaceutical or medical preparations factory. The applicant for the project submits a request to the Technical Affairs Department to study the technical feasibility of the project and the items he wants to produce in order to submit them to the General Directorate of Industrial Development in the Ministry.” Health to obtain initial approval for the submitted plans and study the technical feasibility within a specific period within 7 days, after which work begins on preparing its plans through a consulting party to begin the initial design, then begins implementation. During the implementation stages, the Technical Affairs Department in the Ministry of Health, the National Factories Division, makes periodic visits to avoid mistakes. Any problem will be addressed before the factory is completed.”[/size]
[size=45]Al-Lami added, “After that comes the construction stages, where he submits a request to import production lines from the entities he selects according to the feasibility study and the advisory bodies specified for them, as there are international and European companies as well as Chinese and Indian companies to obtain offers from and select and import the production lines that are supplied by 12 companies.” To 18 months.”[/size]
[size=45]He stated that “after the production lines are completed and before production begins, approval must be obtained from the Ministry of Health for the factory to comply with good pharmaceutical manufacturing conditions according to international specifications and conditions, as it can begin production and the first meals are subject to pharmaceutical examination and control until final approval to begin production.”[/size]
[size=45]He continued: “We now have 18 factories under construction with varying degrees of completion ranging from zero to 98 percent, as they include factories to produce various medicines and medical supplies, including intravenous solutions, syringes, and medicines that include eye drops and ampoules used as treatment, analgesics, ointments, creams, syrups, antibiotics, and other medicines.” Chronic diseases, as 14 types of medicine have been registered so far to treat patients with type 2 diabetes, and they are new for the first time registered with us as a result of the program to localize the pharmaceutical industry, in addition to 18 types of medicines for treating patients with high blood pressure, which are also new, in addition to what we already have. Medicines to treat patients with type 2 diabetes. As for antibiotics, there are 14 new types of them that cover most cases of severe and moderate infections, and their registration has been completed. If the requirements for their production are completed after registration, the factory begins requesting primary materials, secondary requirements, filling and wrapping supplies, and secondary materials that are included in the pharmaceutical formulation, and it takes A period between 6 to 9 months, meaning that the medicines that are registered now will begin production at the end of the current year or the beginning of next year and will actually enter the market and be in accordance with the highest international specifications and at a price that does not exceed 25 percent of the current price of medicines that are imported from companies.”[/size]
[size=45]He confirmed that “there are 56 new applications to establish factories that received initial approval from the Ministry of Health, distributed among different governorates, from the southern and central governorates to Baghdad to Salah al-Din, Nineveh, and the Kurdistan region.”[/size]
[size=45]He pointed out, “This indicates investors’ confidence that the government is moving forward with supporting the pharmaceutical industries in order to provide citizens with safe and excellent quality medicines and avoid counterfeit medicines.”[/size]
[size=45]Regarding chronic disease medications, Al-Lami explained, “There are more than 100 files under study in the Technical Affairs Department in the Ministry of Health to add new items to the national list at the end of next year, meaning that most of the chronic disease medications that the sick citizen needs, antibiotics, and painkillers will be covered.” Ointments, creams, cough medicines, etc.[/size]
[size=45]He added: “As for medicines that need a technology transfer process, it takes 5 years, and we started last year, the first year of the current government, in accordance with the localization decisions, allowing the transfer of technology in stages over a period of 5 years.”[/size]
[size=45]He pointed out that “the first stage is the secondary packaging process, and the agreement must be with a well-known international company registered with the Ministry of Health and having international certificates to begin with. Therefore, the transfer of technology will take place from a reputable company, starting with secondary packaging, then we move to the semi-manufacturing process in Iraq, and we end at the end of the five years with the transfer.” The technological file is complete, and our possession of the file and production is entirely Iraqi with regard to blood disease medicines, cancer medicines, and medicines for treating type 1 diabetics and insulin. As for the common medicines that the citizen needs, they will be available to the citizen at the end of next year.”[/size]
[size=45][You must be registered and logged in to see this link.]